國立虎尾科技大學 |

Radiopharmaceuticals in the Management of Leptomeningeal Metastasis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Radiopharmaceuticals in the Management of Leptomeningeal Metastasis/ edited by Franklin C.L. Wong.
其他作者:	Wong, Franklin C.L.
面頁冊數:	XI, 232 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Neurology. -
電子資源:	https://doi.org/10.1007/978-3-031-14291-8
ISBN:	9783031142918

Radiopharmaceuticals in the Management of Leptomeningeal Metastasis
Radiopharmaceuticals in the Management of Leptomeningeal Metastasis[electronic resource] /edited by Franklin C.L. Wong. - 1st ed. 2022. - XI, 232 p.online resource.

Human Leptomeningeal Metastasis (LM)- Epidemiology and Challenges -- State of Art of LM Radiographic Diagnosis – Anatomic and Functional Imaging -- State of Art of LM Therapies: Intrathecal and Systemic approaches -- Current Practice of Radiation Therapy of LM -- Radionuclides in the Diagnosis and Therapy in Neuro-Oncology -- Radionuclide LM Therapy - Published Clinical Trial Findings -- Intrathecal LM Dosimetry Models- Radionuclides in CSF Spaces -- Human Radiation Dosimetry from Imaging- Guidance for Therapy -- Radiographic Assessment for Monitoring of LM Treatment -- Clinical Assessment for Monitoring of LM Treatment -- Logistic and Regulatory Aspects of Locoregional Radionuclide Therapy -- Radionuclides in the Management of LM– Challenges and Opportunities.

This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy. LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM. The scientific bases of using radionuclides inside human CSF and ablating LM will be discussed within the text, with results from established and completed clinical trials to explore optimal use of radionuclides to diagnose and treat LM. Many limitations of current practices of treating LM are also discussed, as well as potential avenues of overcoming these limitations. This book is an ideal guide for clinical researchers in the practice of treating leptomeningeal metastasis including radiologists, neurologists, oncologists and radiotherapists as well as their associates.

ISBN: 9783031142918

Standard No.: 10.1007/978-3-031-14291-8doiSubjects--Topical Terms:

593894
Neurology.

LC Class. No.: R895-920

Dewey Class. No.: 616.0757

Radiopharmaceuticals in the Management of Leptomeningeal Metastasis
LDR:03170nam a22003855i 4500 001 1085417
003 DE-He213
005 20221112145953.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783031142918 $9 978-3-031-14291-8
024 7 $a 10.1007/978-3-031-14291-8 $2 doi
035 $a 978-3-031-14291-8
050 4 $a R895-920
072 7 $a MMP $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKS $2 thema
082 0 4 $a 616.0757 $2 23
245 1 0 $a Radiopharmaceuticals in the Management of Leptomeningeal Metastasis $h [electronic resource] / $c edited by Franklin C.L. Wong.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XI, 232 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Human Leptomeningeal Metastasis (LM)- Epidemiology and Challenges -- State of Art of LM Radiographic Diagnosis – Anatomic and Functional Imaging -- State of Art of LM Therapies: Intrathecal and Systemic approaches -- Current Practice of Radiation Therapy of LM -- Radionuclides in the Diagnosis and Therapy in Neuro-Oncology -- Radionuclide LM Therapy - Published Clinical Trial Findings -- Intrathecal LM Dosimetry Models- Radionuclides in CSF Spaces -- Human Radiation Dosimetry from Imaging- Guidance for Therapy -- Radiographic Assessment for Monitoring of LM Treatment -- Clinical Assessment for Monitoring of LM Treatment -- Logistic and Regulatory Aspects of Locoregional Radionuclide Therapy -- Radionuclides in the Management of LM– Challenges and Opportunities.
520 $a This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy. LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM. The scientific bases of using radionuclides inside human CSF and ablating LM will be discussed within the text, with results from established and completed clinical trials to explore optimal use of radionuclides to diagnose and treat LM. Many limitations of current practices of treating LM are also discussed, as well as potential avenues of overcoming these limitations. This book is an ideal guide for clinical researchers in the practice of treating leptomeningeal metastasis including radiologists, neurologists, oncologists and radiotherapists as well as their associates.
650 2 4 $a Neurology. $3 593894
650 2 4 $a Internal Medicine. $3 668583
650 0 $a Neurology . $3 1253459
650 0 $a Internal medicine. $3 644638
650 0 $a Radiology. $3 673943
700 1 $a Wong, Franklin C.L. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1354776
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783031142901
776 0 8 $i Printed edition: $z 9783031142925
856 4 0 $u https://doi.org/10.1007/978-3-031-14291-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)